Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

LondonMetric sells further six assets, acquisitions boost portfolio value by £7.3bn

(Sharecast News) - Real estate investment trust LondonMetric said on Wednesday that it has sold a further six assets for £42.6m since its FY results announcement in May. So far this financial year, LondonMetric has sold 14 assets for £106.0m, in line with 31 March 2025 book values.

LondonMetric said that the recent acquisitions of Highcroft Investment and Urban Logistics REIT had increased the value of its portfolio by £7.3bn, which it said had continued to "perform well", with occupier demand remaining strong.

Since 31 March, LondonMetric noted that it has added £3.1m per annum of additional rent from asset management initiatives, while it also said 59 rent reviews had been settled, adding £2.4m per annum, at an average uplift of 16% above previous passing rent on a five-yearly equivalent basis.

LondonMetric also stated that as part of the Urban Logistics and Highcroft acquisitions, it has taken on secured debt facilities of £484.0m at an average drawn rate of 4.26%. Available debt facilities now total £1.0bn, providing "significant optionality" to finance future transactions and debt expiries.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.